Urinary Glucose Concentration as a Predictor of Proteinuria Reduction in Chronic Kidney Disease Patients Treated with Sodium-Glucose Cotransporter 2 Inhibitors.

Article B Peer reviewed Small trial

Key takeaways

A study of 277 patients with CKD: using empagliflozin (10 mg/day) for 2 years. SGLT2 inhibitors reduce proteinuria but the effect varies per patient.

Wang X · Wang J · Zhou S · Yang Z · Duan Z · Wang Y · Dong Z · Wu J · Chen X · Cai G

Article · PubMed, Reducing protein and albumin in urine · 2026 Jul 14
https://pubmed.ncbi.nlm.nih.gov/42610122/